Skip to content
Publish & Distribute
Publishing Solutions
Distribution Solutions
Library Services
Subjects
Architecture and Design
Arts
Business and Economics
Chemistry
Classical and Ancient Near Eastern Studies
Computer Sciences
Cultural Studies
Engineering
General Interest
Geosciences
History
Industrial Chemistry
Jewish Studies
Law
Library and Information Science, Book Studies
Life Sciences
Linguistics and Semiotics
Literary Studies
Materials Sciences
Mathematics
Medicine
Music
Pharmacy
Philosophy
Physics
Social Sciences
Sports and Recreation
Theology and Religion
Publications
Journals
Books
Proceedings
Publishers
Journal Matcher
Blog
Contact
Search
English
English
Deutsch
Polski
Español
Français
Italiano
Cart
Home
Journals
Acta Pharmaceutica
Volume 70 (2020): Issue 2 (June 2020)
Open Access
Biopharmaceutical classification of desloratadine – not all drugs are classified the easy way
Katja Berginc
Katja Berginc
Ljubljana, Slovenia
Search for this author on
Sciendo
|
Google Scholar
Berginc, Katja
,
Nadica Sibinovska
Nadica Sibinovska
Ljubljana, Slovenia
University of Ljubljana, Faculty of Pharmacy, Chair of Biopharmaceutics and Pharmacokinetics
Ljubljana, Slovenia
Search for this author on
Sciendo
|
Google Scholar
Sibinovska, Nadica
,
Simon Žakelj
Simon Žakelj
University of Ljubljana, Faculty of Pharmacy, Chair of Biopharmaceutics and Pharmacokinetics
Ljubljana, Slovenia
Search for this author on
Sciendo
|
Google Scholar
Žakelj, Simon
,
Jurij Trontelj
Jurij Trontelj
University of Ljubljana, Faculty of Pharmacy, Chair of Biopharmaceutics and Pharmacokinetics
Ljubljana, Slovenia
Search for this author on
Sciendo
|
Google Scholar
Trontelj, Jurij
and
Igor Legen
Igor Legen
Ljubljana, Slovenia
Search for this author on
Sciendo
|
Google Scholar
Legen, Igor
Jan 16, 2020
Acta Pharmaceutica
Volume 70 (2020): Issue 2 (June 2020)
About this article
Previous Article
Next Article
Abstract
References
Authors
Articles in this Issue
Preview
PDF
Cite
Share
Download Cover
Published Online:
Jan 16, 2020
Page range:
131 - 144
Accepted:
May 31, 2019
DOI:
https://doi.org/10.2478/acph-2020-0006
Keywords
desloratadine
,
BCS-based bio-waiver
,
luminal stability
,
permeability
,
dissolution
© 2020 Katja Berginc et al., published by Sciendo
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.
